Content and data provided by various third parties and Fidelity - Terms of Use

ETF / ETP Details

RELATED RESOURCES

Portfolio Composition: SPCX

SPAC AND NEW ISSUE ETF

28.90up0.01 (0.0346%)

 as of 4:10:00pm ET 09/24/2021

ETP's Prospectus Stated Objectives

The investment seeks to provide total return. In pursuing the fund's investment objective, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in units and shares of Special Purpose Acquisitions Companies (“SPACs”) that have a minimum capitalization of $100 million and companies that completed an initial public offering (“IPO”) within the last two years. The fund may also invest in depositary receipts for cash management purposes or due to a lack of suitable investment opportunities, the fund may hold up to 20% of its net assets in cash or similar short-term, high-quality debt securities.

Asset Classification Equity
Investment Philosophy Actively Managed

ETP Portfolio Characteristics

as of 08/31/2021

Independent third-party analytics of the daily holdings shown below can help you compare the ETP's Prospectus Stated Objectives to the characteristics of its underlying holdings. Their use of standardized calculations enable consistent comparison. It is important to note that they may not reflect ETF Managers' methodology to determine portfolio characteristics in buying and selling securities for the fund. Learn more about the ETF Managers' investment approach and performance in their Prospectus & Reports.

Holdings

Total: 121 (Long: 121 | Short: --)
Holdings
Top 10 27.00%
Other 73.00%

Top 10
AAQC Accelerate Acquisition Corp 4.76%
APSG Apollo Strategic Growth Capital 3.53%
PRPB CC Neuberger Principal Holdings II 3.32%
CRHC Cohn Robbins Holdings Corp 2.68%
Global Consumer PCL 2.30%
Adara Sponsor Llc B Share 2.28%
CCAC CITIC Capital Acquisition Corp 2.15%
ETAC E.Merge Technology Acquisition Corp 2.12%
CLOEU Clover Leaf Capital Corp 1.95%
AVAN Avanti Acquisition Corp 1.91%
View all Holdings by Weight

Sector Exposure

Sector Exposure
 Health Care 1.01%
Industrials 0.12%

Industry Exposure

Health Care Providers & Services 1.01%
Machinery 0.12%

Regional Exposure

Regional Exposure
 North America 89.79%
Asia 7.93%
Europe 2.27%
Africa 0.00%
Middle East 0.00%
Latin America 0.00%

Country Exposure

Country Exposure
 United States 89.79%
Hong Kong 3.29%
Thailand 2.40%
United Kingdom 2.28%
China 2.25%

Market Capitalization

Market Capitalization
 Micro 95.80%
Small 4.20%
Large 0.00%
Mid 0.00%
Free commission offer applies to online purchases select ETFs in a Fidelity brokerage account. The sale of ETFs is subject to an activity assessment fee (from $0.01 to $0.03 per $1,000 of principal). ETFs are subject to market fluctuation and the risks of their underlying investments. ETFs are subject to management fees and other expenses. Unlike mutual funds, ETF shares are bought and sold at market price, which may be higher or lower than their NAV, and are not individually redeemed from the fund.

Data provided by XTF Inc. except where noted. All rights reserved.

Top basket holdings, asset allocation, market sectors, industry exposure, and geographical diversification are as of the date indicated and may not be representative of the funds current or future investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF’s prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock Inc., and its affiliates.

Fidelity receives compensation from the funds advisor or its affiliates in connection with a licensing agreement to utilize Fidelity’s active ETF methodology which may create incentives for FBS to encourage the purchase of certain ETFs.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

© 2010 Morningstar, Inc. All rights reserved. The Morningstar information contained herein (1) is proprietary to Morningstar or its affiliates; (2) may not be copied or redistributed; and (3) is not warranted to be accurate, complete, or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.

888171.1.0

© 1998－2021 FMR LLC.

All rights reserved.